The Journal of Organic Chemistry
Note
6.91 (t, J = 8.2 Hz, 1H), 6.49 (d, J = 8.4 Hz, 2H), 6.41 (dd, J = 8.2 Hz,
2.4 Hz, 2H), 6.35 (t, J = 2.3 Hz, 1H), 5.41 (s, 2H), 4.53 (dAB, J = 15.1
Hz, 2H), 4.40 (dAB, J = 15.1 Hz, 2H), 4.18−4.15 (m, 2H), 4.06−3.98
(m, 2H), 3.88−3.81 (m, 2H), 3.44−3.35 (m, 2H). 13C{1H} NMR (100
MHz, DMSO-d6): δ 167.6, 159.5, 152.2, 137.1, 136.8, 132.1, 130.3,
129.6, 128.1, 124.7, 107.6, 106.5, 106.4, 69.3, 68.4, 67.3, 37.8. HRMS
(ESI, MeOH): m/z calcd for C27H26N2O7Cl2Na [M + Na]+ 583.1015,
found 583.0998. Anal. Calcd for C27H26N2O7Cl2: C, 57.76; H, 4.67; N,
4.99. Found: C, 58.01; H, 4.70; N, 4.92.
Macrocyclic Compound 18. Following general procedure C, the
product (0.9 g, 18%) was obtained after recrystallization from a
methanol/pentane mixture as colorless crystals (mp 117−118 °C).
Following general procedure D, the product (0.62 g, 99%) was obtained
after recrystallization from a methanol/pentane mixture as colorless
crystals. 1H NMR (400 MHz, DMSO-d6): δ 7.45−7.33 (m, 7H), 6.93
(t, J = 8.4 Hz, 1H), 6.54 (d, J = 8.4 Hz, 2H), 6.0 (m, 3H), 5.0 (s, 2H),
4.53 (dAB, J = 15.1 Hz, 2H), 4.40 (dAB, J = 15.1 Hz, 2H), 4.03−3.97 (m,
2H), 3.95−3.86 (m, 4H), 3.73 (s, 3H), 3.40−3.30 (m, 2H). 13C{1H}
NMR (100 MHz, DMSO-d6): δ 168.1, 161.6, 160.3, 152.2, 138.1,
136.6, 129.3, 128.6, 128.5, 124.8, 108.8, 98.4, 93.9, 76.7, 69.1, 67.1,
55.4, 38.1. HRMS (ESI, MeOH): m/z calcd for C28H30N2O8Na [M +
Na]+ 545.1900, found 545.1912. Anal. Calcd for C28H30N2O8: C,
64.36; H, 5.79; N, 5.79. Found: C, 64.43; H, 5.98; N, 5.42.
Macrocyclic Compound 22. Following general procedure C, the
product (1.6 g, 27%) was obtained after recrystallization from a
methanol/pentane mixture as yellowish crystals (mp 136−139 °C).
Following general procedure D, the product (0.50 g, 72%) was obtained
after recrystallization from a methanol/pentane mixture as yellowish
crystals. 1H NMR (400 MHz, DMSO-d6): δ 8.14 (d, J = 8.7 Hz, 2H),
7.54 (d, J = 8.7 Hz, 2H), 7.35 (bm, 2H), 7.0 (t, J = 8.4 Hz, 1H), 6.58 (d,
J = 8.4 Hz, 2H), 5.87 (t, J = 2.1 Hz, 1H), 5.8 (d, J = 2.1 Hz, 2H), 5.06 (s,
2H), 4.59 (dAB, J = 15.1 Hz, 2H), 4.49 (dAB, J = 15.1 Hz, 2H), 4.09−4.04
(m, 2H), 4.02−3.96 (m, 2H), 3.91−3.83 (m, 2H), 3.46−3.39 (m, 2H),
2.91 (s, 6H). 13C{1H} NMR (100 MHz, DMSO-d6): δ 167.6, 160.1,
152.3, 151.6, 147.5, 143.5, 137.5, 128.9, 124.9, 123.2, 108.3, 94.9, 92.3,
74.7, 68.7, 67.1, 40.2, 38.2. HRMS (ESI, MeOH): m/z calcd for
C29H32N4O9Na [M + Na]+ 603.2067, found 603.2055. Anal. Calcd for
C29H32N4O9: C, 59.99; H, 5.56; N, 9.65. Found: C, 59.70; H, 5.63; N,
9.58.
Macrocyclic Compound 23. Following general procedure C the
product (1.3 g, 21%) was obtained after recrystallization from a
methanol/pentane mixture as colorless crystals (mp 193−194 °C).
Following general procedure D, the product (0.62 g, 86%) was obtained
after recrystallization from a methanol/pentane mixture as colorless
crystals. 1H NMR (400 MHz, DMSO-d6): δ 7.57 (dd, J = 7.4, 3.6 Hz,
2H), 7.46 (d, J = 7.8 Hz, 2H), 7.37 (dd, J = 8.7, 7.4 Hz, 1H), 6.83 (t, J =
8.4 Hz, 1H), 6.64 (d, J = 8.4 Hz, 2H), 5.78 (d, J = 2.0 Hz, 2H), 5.64 (t, J
= 1.9 Hz, 1H), 5.32 (s, 2H), 4.43 (dAB, J = 15.2 Hz, 4H), 4.05−3.99 (m,
2H), 3.87−3.80 (m, 2H), 3.72−3.64 (m, 2H), 3.28−3.21 (m, 2H), 2.82
(s, 6H). 13C{1H} NMR (100 MHz, DMSO-d6): δ 167.7, 160.3, 152.2,
152.1, 137.0, 132.1, 130.3, 128.1, 124.8, 107.9, 94.5, 92.1, 69.3, 68.6,
66.9, 40.3, 38.0. HRMS (ESI, MeOH): m/z calcd for
C29H31N3O7Cl2Na [M + Na]+ 626.1437 (monoisotopic mass), found
626.1452. Anal. Calcd for C30H33N3O7Cl4 (C29H31N3O7Cl2·CH2Cl2):
C, 57.62; H, 5.17; N, 6.95; Cl, 11.73. Found: C, 57.49; H, 5.07; N, 6.85;
Cl, 11.63.
Macrocyclic Compound 24. Following general procedure E, the
product (3.9 g, 9.8 mmol, 98%) was obtained as a colorless amorphous
powder. 1H NMR (400 MHz, DMSO-d6): δ 9.21 (s, 1H), 8.32 (t, J =
5.7 Hz, 2H), 7.06 (t, J = 8.2 Hz, 1H), 6.78 (s, 1H), 6.71−6.64 (m, 3H),
6.41 (dd, J = 8.2, 2.2 Hz, 2H), 4.41 (s, 4H), 4.04 (t, J = 4.8 Hz, 4H), 3.56
(dd, J = 10.0, 5.0 Hz, 4H). 13C{1H} NMR (100 MHz, DMSO-d6): δ
168.0, 160.0, 146.7, 136.9, 129.6, 118.8, 109.9, 107.4, 103.8, 69.5, 67.0,
38.1. HRMS (ESI, MeOH): m/z calcd for C20H22N2O7Na [M + Na]+
425.1325, found 425.1312. Anal. Calcd for C20H22N2O7: C, 59.70; H,
5.51; N, 6.96. Found: C, 58.14; H, 5.52; N, 6.79.
Macrocyclic Compound 25. Following general procedure E, the
product (4.3 g, 99%) was obtained as a colorless amorphous powder.
1H NMR (400 MHz, DMSO-d6): δ 9.21 (s, 1H), 8.32 (t, J = 5.7 Hz,
2H), 7.06 (t, J = 8.2 Hz, 1H), 6.78 (s, 1H), 6.71−6.64 (m, 3H), 6.41
(dd, J = 8.2, 2.2 Hz, 2H), 4.41 (s, 4H), 4.04 (t, J = 4.8 Hz, 4H), 3.56 (dd,
J = 10.0, 5.0 Hz, 4H). 13C{1H} NMR (100 MHz, DMSO-d6): δ 168.0,
160.0, 146.7, 136.9, 129.6, 118.8, 109.9, 107.4, 103.8, 69.5, 67.0, 38.1.
HRMS (ESI, MeOH): m/z calcd for C21H24N2O8Na [M + Na]+
455.1430, found 455.1445. Anal. Calcd for C21H24N2O8·(CH3OH)0.5:
C, 57.58; H, 5.84; N, 6.25. Found: C, 57.55; H, 5.82; N, 6.31.
Macrocyclic Compound 26. Following general procedure E, the
product (4.4 g, 98%) was obtained as a colorless amorphous powder.
1H NMR (400 MHz, DMSO-d6): δ 9.29 (s, 1H), 8.47 (bs, 2H), 6.73 (s,
3H), 6.19 (s, 1H), 5.77 (s, 2H), 4.46 (s, 4H), 4.06 (t, J = 4.4 Hz, 4H),
3.58 (m, 4H), 2.86 (s, 6H). 13C{1H} NMR (100 MHz, DMSO-d6): δ
168.9, 161.2, 147.5, 137.8, 119.6, 110.9, 107.8, 103.4, 93.5, 70.4, 67.4,
41.7, 39.1. HRMS (ESI, MeOH): m/z calcd for C22H28N3O7 [M + H]+
446.1922, found 446.1938.
Macrocyclic Compound 19. Following general procedure C, the
product (0.6 g, 11%) was obtained after recrystallization from a
methanol/pentane mixture as yellowish crystals (mp 131−133 °C).
Following general procedure D, the product (0.49 g, 72%) was obtained
after recrystallization from a methanol/pentane mixture as yellowish
crystals. 1H NMR (400 MHz, DMSO-d6): δ 7.46 (bm, 2H), 7.38 (m,
2H), 7.32 (m, 3H), 6.95 (t, J = 8.4 Hz, 1H), 6.55 (d, J = 8.4 Hz, 2H),
5.86 (t, J = 2.1 Hz, 1H), 5.81 (d, J = 2.1 Hz, 2H), 4.99 (s, 2H), 4.51 (dAB
,
J = 15.0 Hz, 2H), 4.40 (dAB, J = 15.0 Hz, 2H), 4.05−4.00 (m, 2H),
3.98−3.94 (m, 2H), 3.93−3.87 (m, 2H), 3.40−3.33 (m, 2H), 2.89 (s,
6H). 13C{1H} NMR (100 MHz, DMSO-d6): δ 168.1, 160.4, 152.5,
152.3, 138.1, 136.6, 129.4, 128.6, 128.4, 124.8, 108.9, 94.5, 92.6, 76.6,
69.2, 67.0, 40.6, 38.4. HRMS (ESI, MeOH): m/z calcd for
C28H29N3O10Na [M + Na]+ 590.1751, found 590.1745. Anal. Calcd
for C28H29N3O10: C, 59.26; H, 5.15; N, 7.40. Found: C, 58.88; H, 5.30;
N, 7.37.
Macrocyclic Compound 20. Following general procedure C, the
product (2.0 g, 34%) was obtained after recrystallization from a
methanol/pentane mixture as colorless crystals (mp 205−207 °C).
Following general procedure D, the product (0.59 g, 85%) was obtained
after recrystallization from a methanol/pentane mixture as colorless
crystals. 1H NMR (400 MHz, DMSO-d6): δ 7.54 (bm, 2H), 7.31 (d, J =
8 Hz, 2H), 7.19 (t, J = 8.5 Hz, 2H), 6.94 (t, J = 8.4 Hz, 1H), 6.51 (d, J =
8.4 Hz, 1H), 5.97 (m, 3H), 5.41 (s, 2H), 4.52 (dAB, J = 15.1 Hz, 2H),
4.40 (dAB, J = 15.1 Hz, 2H), 4.13−4.05 (m, 2H), 4.03−3.97 (m, 2H),
3.89−3.82 (m, 2H), 3.72 (s, 3H), 3.44−3.35 (m, 2H). 13C NMR (100
MHz, DMSO-d6): δ 167.6, 161.2, 160.1, 152.2, 137.0, 136.9, 132.1,
130.4, 128.1, 124.8, 98.6, 93.4, 69.3, 68.5, 67.2, 55.1, 37.8. HRMS (ESI,
MeOH): m/z calcd for C28H28N2O8Cl2Na [M + Na]+ 613.1120, found
613.1130. Anal. Calcd for C28H28N2O8Cl2: C, 56.86; H, 4.77; N, 4.74.
Found: C, 56.90; H, 4.79; N, 4.63.
Macrocyclic Compound 21. Following general procedure C, the
product (1.4 g, 26%) was obtained after recrystallization from a
methanol/pentane mixture as colorless crystals (mp 104−107 °C).
Following general procedure D, the product (0.63 g, 98%) was obtained
after recrystallization from a methanol/pentane mixture as colorless
crystals. 1H NMR (400 MHz, DMSO-d6): δ 7.46 (bm, 2H), 7.38 (m,
2H), 7.32 (m, 3H), 6.95 (t, J = 8.4 Hz, 1H), 6.55 (d, J = 8.4 Hz, 2H),
5.86 (t, J = 2.1 Hz, 1H), 5.81 (d, J = 2.1 Hz, 2H), 4.99 (s, 2H), 4.51 (dAB
,
Macrocyclic Compound 27. Following general procedure D, the
product (0.15 g, 63%) was obtained as a yellowish crystalline powder
(mp 105−106 °C). 1H NMR (400 MHz, CDCl3): δ 9.02 (d, J = 9.4 Hz,
1H), 8.28 (dd, J = 11.1, 4.6 Hz, 3H), 8.25−8.15 (m, 3H), 8.14−8.07
(m, 2H), 7.82 (d, J = 4.0 Hz, 2H), 7.05 (t, J = 8.2 Hz, 1H), 6.91 (t, J =
8.4 Hz, 1H), 6.69 (t, J = 2.3 Hz, 1H), 6.54 (d, J = 8.4 Hz, 2H), 6.41 (dd,
J = 15.0 Hz, 2H), 4.40 (dAB, J = 15.0 Hz, 2H), 4.05−4.00 (m, 2H),
3.98−3.94 (m, 2H), 3.93−3.87 (m, 2H), 3.40−3.33 (m, 2H), 2.89 (s,
6H). 13C{1H} NMR (100 MHz, DMSO-d6): δ 168.1, 160.4, 152.5,
152.3, 138.1, 136.6, 129.4, 128.6, 128.4, 124.8, 108.9, 94.5, 92.6, 76.6,
69.2, 67.0, 40.6, 38.4. HRMS (ESI, MeOH): m/z calcd for
C29H33N3O7Na [M + Na]+ 558.2216, found 558.2200. Anal. Calcd
for C29H33N3O7: C, 65.03; H, 6.21; N, 7.81. Found: C, 65.03; H, 6.40;
N, 7.63.
J = 8.2, 2.3 Hz, 2H), 5.47 (s, 2H), 4.63 (dAB, J = 15.2 Hz, 2H), 4.44 (dAB
,
J = 15.2 Hz, 2H), 4.22 (m, 2H), 4.09−3.94 (m, 4H), 3.40 (m, 2H).
13C{1H} NMR (100 MHz, CDCl3): δ 198.4, 168.2, 160.0, 151.7, 138.4,
F
J. Org. Chem. XXXX, XXX, XXX−XXX